The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Emergence of Tetracycline Resistance in Helicobacter pylori : Multiple Mutational Changes in 16S Ribosomal DNA and Other Genetic Loci
Open accessAbstract
Tetracycline is useful in combination therapies against the gastric pathogen Helicobacter pylori . We found 6 tetracycline-resistant (Tet r ) strains among 159 clinical isolates (from El Salvador, Lithuania, and India) and obtained the following four results: (i) 5 of 6 Tet r isolates contained one or two nucleotide substitutions in one part of the primary tetracycline binding site in 16S rRNA (AGA 965-967 [ Escherichia coli coordinates] changed to gGA, AGc, guA, or gGc [lowercase letters are used to represent the base changes]), whereas the sixth (isolate Ind75) retained AGA 965-967 ; (ii) PCR products containing mutant 16S ribosomal DNA (rDNA) alleles transformed recipient strains to Tet r phenotypes, but transformants containing alleles with single substitutions (gGA and AGc) were less resistant than their Tet r parents; (iii) each of 10 Tet r mutants of reference strain 26695 (in which mutations were induced with metronidazole, a mutagenic anti- H. pylori agent) contained the normal AGA 965-967 sequence; and (iv) transformant derivatives of Ind75 and of one of the Tet r 26695 mutants that had acquired mutant rDNA alleles were resistant to tetracycline at levels higher than those to which either parent strain was resistant. Thus, tetracycline resistance in H. pylori results from an accumulation of changes that may affect tetracycline-ribosome affinity and/or other functions (perhaps porins or efflux pumps). We suggest that the rarity of tetracycline resistance among clinical isolates reflects this need for multiple mutations and perhaps also the deleterious effects of such mutations on fitness. Formally equivalent mutations with small but additive effects are postulated to contribute importantly to traits such as host specificity and virulence and to H. pylori 's great genetic diversity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have shown that mutations G966U and G1058C cause high levels of resistance to tetracycline (22 -24).”
From Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors (2016) · cites this paper as [22]
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Self-citationMalfertheiner, P., Mégraud, F., O'Morain, C. A., Hungin, A. P. S., Jones, R. H., Axon, A. T. R., Graham, D. Y., Tytgat, G. N. J., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,238
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950 · cited 2×
“None of these Tet mutants contained changes in or near the primary tetracycline binding site or in any of the potential secondary binding sites (6, 32) in this 3 half of the 16S rDNA sequence.”
BackgroundHelicobacter pylori SabA Adhesin in Persistent Infection and Chronic Inflammation
Mahdavi, J., Sondén, B., Hurtig, M., Olfat, F. O., Forsberg, L., Roche, N., Ångström, J., Larsson, T. P., Teneberg, S., Karlsson, K., et al. (2002) · Science · doi:10.1126/science.1069076 · Cited by 935
Self-citationThe biological cost of antibiotic resistance
Andersson, D. I., & Levin, B. R. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00005-3 · Cited by 861
Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3
Pioletti, M., Schlünzen, F., Harms, J., Zarivach, R., Glühmann, M., Avila, H., Bashan, A., Bartels, H., Auerbach, T., Jacobi, C., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1829 · Cited by 527
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
Versalovic, J. A., Shortridge, D., Kibler, K., Griffy, M. V., Beyer, J. M., Flamm, R. K., Tanaka, S., Graham, D. Y., & Go, M. F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.477 · Cited by 501
Active efflux mechanisms for antimicrobial resistance
Levy, S. B. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.695 · Cited by 501
Multidrug resistance mechanisms: drug efflux across two membranes
Zgurskaya, H. I., & Nikaido, H. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01926.x · Cited by 466
Cited by
Sorted by citations
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118
H pylori antibiotic resistance: prevalence, importance, and advances in testing
Megraud, F. (2004) · Gut · doi:10.1136/gut.2003.022111 · Cited by 954
Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing
Mégraud, F., & Lehours, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00033-06 · Cited by 725
Tetracycline antibiotics and resistance mechanisms
Nguyen, F., Starosta, A. L., Arenz, S., Sohmen, D., Dönhöfer, A., & Wilson, D. N. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0292 · Cited by 529
Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications
Tshibangu‐Kabamba, E., & Yamaoka, Y. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00449-x · Cited by 546
The emergence of antibiotic resistance by mutation
Woodford, N., & Ellington, M. J. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01492.x · Cited by 417
Thaker, M., Spanogiannopoulos, P., & Wright, G. D. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0172-6 · Cited by 391
Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications
Gerrits, M. M., van Vliet, A. H. M., Kuipers, E. J., & Kusters, J. G. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70627-2 · Cited by 329
Mycobacterium avium in the Postgenomic Era
Turenne, C. Y., Wallace, R. J., & Behr, M. A. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-06 · Cited by 226
rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines
Chukwudi, C. U. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00594-16 · Cited by 208
Hwang, T. J., Kim, N., Kim, H. B., Lee, B. H., Nam, R. H., Park, J. H., Lee, M. K., Park, Y. S., Lee, D. H., Jung, H. C., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d04592 · Cited by 140
Ansari, S., & Yamaoka, Y. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00258-21 · Cited by 160
Tetracyclines in veterinary medicine and bacterial resistance to them
Michalova, E., Pnovotna, P., & Schlegelová, J. (2004) · Veterinární Medicína · doi:10.17221/5681-vetmed · Cited by 136
Fang, L., Chen, C., Cui, C., Li, X., Zhang, Y., Liao, X., Sun, J. G., & Liu, Y. (2020) · BioEssays · doi:10.1002/bies.202000014 · Cited by 132
Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem
Hu, Y., Zhang, M., Lü, B., & Dai, J. (2016) · Helicobacter · doi:10.1111/hel.12299 · Cited by 132
Gaillard, T., Madamet, M., & Pradines, B. (2015) · Malaria Journal · doi:10.1186/s12936-015-0980-0 · Cited by 129
Cluster of Type IV Secretion Genes inHelicobacter pylori's Plasticity Zone
Kersulyte, D., Velapatiño, B., Mukhopadhyay, A. K., Cahuayme, L., Bussalleu, A., Combe, J., Gilman, R. H., & Berg, D. E. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.13.3764-3772.2003 · Cited by 87
Self-citationEffects of 16S rRNA Gene Mutations on Tetracycline Resistance in Helicobacter pylori
Gerrits, M. M., Berning, M., Van Vliet, A. H. M., Kuipers, E. J., & Kusters, J. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2984-2986.2003 · Cited by 75
Wu, J. Y., Kim, J. J., Reddy, R., Wang, W. M., Graham, D. Y., & Kwon, D. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.578-583.2005 · Cited by 74
16S rRNA Gene Mutations Associated with Decreased Susceptibility to Tetracycline in Mycoplasma bovis
Amram, E., Mikula, I., Schnee, C., Ayling, R. D., Nicholas, R. A. J., Rosales, R. S., Harrus, S., & Lysnyansky, I. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03876-14 · Cited by 59
Ribeiro, M. L., Gerrits, M. M., Benvengo, Y. H. B., Berning, M., Godoy, A. P. O., Kuipers, E. J., Mendonça, S., van Vliet, A. H. M., Pedrazzoli, J., & Kusters, J. G. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00277-3 · Cited by 59
Datta, S., Chattopadhyay, S., Patra, R., De, R., Ramamurthy, T., Hembram, J., Chowdhury, A., Bhattacharya, S. K., Berg, D. E., Nair, G. B., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02533.x · Cited by 58
Self-citationNegamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA
Polikanov, Y. S., Szal, T., Jiang, F., Gupta, P., Matsuda, R., Shiozuka, M., Steitz, T. A., Vázquez-Laslop, N., & Mankin, A. S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.021 · Cited by 57
Cocozaki, A. I., Altman, R. B., Huang, J., Buurman, E. T., Kazmirski, S. L., Doig, P., Prince, D. B., Blanchard, S. C., Cate, J. H. D., & Ferguson, A. D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605127113 · Cited by 56
Antibiotic Resistance of Helicobacter pylori : Mechanisms and Clinical Implications
Hasanuzzaman, M., Bang, C. S., & Gong, E. J. (2024) · Journal of Korean Medical Science · doi:10.3346/jkms.2024.39.e44 · Cited by 70
Nonaka, L., Connell, S. R., & Taylor, D. E. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.11.3708-3712.2005 · Cited by 55
Molecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance
Mégraud, F., Bénéjat, L., Ngoyi, E. N. O., & Lehours, P. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.05.002 · Cited by 54
Glocker, E. O., Berning, M., Gerrits, M. M., Kusters, J. G., & Kist, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3166-3170.2005 · Cited by 54
Lawson, A., Elviss, N. C., & Owen, R. J. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki199 · Cited by 51
Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo
Ngoyi, E. N. O., Ibara, B. I. A., Moyen, R., Apendi, P. C. M. A., Ibara, J. R., Obengui, O., Ibara, R. B. O., Nguimbi, E., Niama, R. F., Ouamba, J. M., et al. (2015) · Helicobacter · doi:10.1111/hel.12204 · Cited by 51
Secka, O., Berg, D. E., Antonio, M., Corrah, T., Tapgun, M., Walton, R. T., Thomas, V. O. H., Galano‐Frutos, J. J., Sancho, J., Adegbola, R. A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00517-12 · Cited by 50
Self-citationWang, Y., Li, Z., Wang, L., Zhuge, L., Zhao, R., Wu, S., Wang, Y., An, Y., & Xie, Y. (2018) · Helicobacter · doi:10.1111/hel.12467 · Cited by 51
Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection
Ng, H. Y., Leung, W. K., & Cheung, K. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411708 · Cited by 47
Pringle, M., Fellström, C., & Johansson, K. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.02.019 · Cited by 46
Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori
Anoushiravani, M., Falsafi, T., & Niknam, V. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.010876-0 · Cited by 46
Binet, R., & Maurelli, A. T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4455-4464.2005 · Cited by 46
Morris, J. M., Reasonover, A. L., Bruce, M. G., Bruden, D. L., McMahon, B. J., Sacco, F. D., Berg, D. E., & Parkinson, A. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3494-3496.2005 · Cited by 40
Self-citationFrequency of Spontaneous Mutations That Confer Antibiotic Resistance in Chlamydia spp
Binet, R., & Maurelli, A. T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2865-2873.2005 · Cited by 39
Dailidiene, D., Dailide, G., Ogura, K., Zhang, M., Mukhopadhyay, A. K., Eaton, K. A., Cattoli, G., Kusters, J. G., & Berg, D. E. (2003) · Journal of Bacteriology · doi:10.1128/jb.186.2.356-365.2004 · Cited by 35
Self-citationMerkx-Jacques, A., Obhi, R. K., Bethune, G., & Creuzenet, C. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.8.2253-2265.2004 · Cited by 34
Tetracycline resistance in Chilean clinical isolates of Helicobacter pylori
Toledo, H., & López‐Solís, R. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp457 · Cited by 33
Whos Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori
Jones, K. R., Cha, J., & Merrell, D. S. (2008) · Current Drug Therapy · doi:10.2174/157488508785747899 · Cited by 33
Zhou, Y., Zhong, Z., Hu, S., Wang, J., Deng, Y., Li, X., Chen, X., Li, X., Tang, Y., Li, X., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02188-21 · Cited by 33
Dadashzadeh, K., Milani, M., Rahmati, M., & Akbarzadeh, A. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.20.8883 · Cited by 30
Gong, R., Xu, C., Li, H., & Liu, X. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i1.133 · Cited by 31
Webb, J. R., Price, E. P., Currie, B. J., & Sarovich, D. S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00268-17 · Cited by 28
Lupien, A., Gingras, H., Bergeron, M. G., Leprohon, P., & Ouellette, M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv060 · Cited by 28
Li, Y., & Dannelly, H. K. (2006) · Archives of Microbiology · doi:10.1007/s00203-006-0093-9 · Cited by 27
Structural Aspects of Helicobacter pylori Antibiotic Resistance
Zanotti, G., & Cendron, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_368 · Cited by 26
Idris, A. B., Hassan, H. G., Ali, M. A. S., Eltaher, S. M., Idris, L. B., Altayb, H. N., Abass, A. M., Ibrahim, M. M. A., Ibrahim, E.-A. M., & Hassan, M. A. S. (2020) · International Journal of Microbiology · doi:10.1155/2020/8825718 · Cited by 29
Saraiya, A. A., Lamichhane, T. N., Chow, C. S., SantaLucia, J., & Cunningham, P. R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.102 · Cited by 23
Molecular Characterization of Benzimidazole Resistance in Helicobacter pylori
Mills, S. D., Yang, W., & MacCormack, K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2524-2530.2004 · Cited by 22
Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective
Elbaiomy, R. G., Luo, X., Guo, R., Deng, S., Du, M., El‐Sappah, A. H., Bakeer, M. S., Azzam, M. M., Elolimy, A. A., Madkour, M., et al. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00704-5 · Cited by 21
Chua, T.-P., Danielewski, J., Bodiyabadu, K., Bradshaw, C. S., Machalek, D. A., Garland, S. M., Plummer, E. L., Vodstrcil, L. A., & Murray, G. L. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00243-22 · Cited by 21
Kupčinskas, L., Rasmussen, L., Jonaitis, L. V., Kiudelis, G., Jørgensen, M. H., Urbonavičienė, N., Tamošiūnas, V., Kupčinskas, J., Miciulevičienė, J., Kaduševičius, E., et al. (2012) · Apmis · doi:10.1111/apm.12012 · Cited by 21
Self-citationZhou, K., Li, C., Zhang, H., Suo, B., Zhang, Y., Ren, X., Wang, Y., Mi, C., Ma, L.-L., Zhou, L., et al. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i17.2354 · Cited by 19
Mutational Analysis of the Ribosome
Triman, K. L. (2007) · Advances in genetics · doi:10.1016/s0065-2660(06)58004-6 · Cited by 19
Aldana, A. Á., Moncayo-Ortíz, J. I., Santacruz, J. J., Corredor, L. F., Reinosa, E., Martínez, J. W., & Beltrán, L. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009001000005 · Cited by 19
Mosquera-Rendón, J., Cárdenas-Brito, S., Pineda, J. D., Corredor, M., & Benítez‐Páez, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-440 · Cited by 17
Hibernating ribosomes as drug targets?
Ekemezie, C. L., & Melnikov, S. V. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1436579 · Cited by 19
Simala‐Grant, J. L., & Taylor, D. E. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm11211-1211.x · Cited by 15
Kuang, Z., Wu, Y., Xie, X., Zhao, X., Chen, H., Wu, L., Gao, H., Zhao, H., Liang, T., Zhang, J., et al. (2025) · Helicobacter · doi:10.1111/hel.70007 · Cited by 14
Yu, J., Kaw, H. Y., Yang, Q., Fan, C., Ma, X., Zhu, L., & Wang, W. (2026) · Nature Water · doi:10.1038/s44221-025-00564-y · Cited by 10
Barathan, M., Wahid, W., Sukri, A., & Hanafiah, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136064 · Cited by 10
Suto, H., Zhang, M., & Berg, D. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.1232-1234.2005 · Cited by 10
Self-citation[Bacterial resistance of Helicobacter pylori in the world in 2009].
Mégraud, F., & Corti, R. (2009) · PubMed · Cited by 10
Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares
Cristián Vallejos, M., Cerda, O., Valenzuela, M., & Héctor Toledo, A. (2003) · Revista médica de Chile · doi:10.4067/s0034-98872003001100014 · Cited by 10
Khan, R., Nahar, S., Mukhopadhyay, A. K., Berg, D. E., Ahmad, M. M., Okamoto, K., Nair, G. B., & Rahman, M. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00062.x · Cited by 9
Self-citationSen, S. P., & Sarkar, K. (2018) · Annals of Agrarian Science · doi:10.1016/j.aasci.2018.04.005 · Cited by 10
Suzuki, R. B., Almeida, C. M., & Sperança, M. A. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-49 · Cited by 9
Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024
Wu, P., Tsay, F., Wu, D., Yang, J., Chuah, S., Chen, K.-Y., Chen, C., Lee, C., Shih, C., Liu, Y., et al. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i39.111380 · Cited by 8
Mutations associated with Helicobacter pylori antimicrobial resistance in the Ecuadorian population
Zurita, J., Sevillano, G., y Miño, A. P., Zurita-Salinas, C. S., Peñaherrera, V., Echeverría, M., Navarrete, H., Casares, M. Á. S., Narváez, I. O., Yépez, J. E., et al. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15396 · Cited by 8
Antimicrobial Resistance and Drug Efflux Pumps in Acinetobacter
Ling, B., Zhang, L., & Li, X.-Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_13 · Cited by 9
Si, X., Bi, D.-Y., Lan, Y., Zhang, S., & Huo, L.-Y. (2020) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2020.20025 · Cited by 7
[Diagnosis of Helicobacter pylori by polymerase chain reaction].
Premoli, G., González, A., Millán-Mendoza, B., Percoco, T., & Vielma, A. (2004) · PubMed · Cited by 7
Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori
Gerrits, M. M. (2004) · RePub (Erasmus University Rotterdam) · Cited by 5
An, B., Moon, B. S., Lim, H. C., Lee, Y. C., Kim, H., Lee, G., Kim, S.-H., Park, M., & Kim, J. B. (2014) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2014.14.2.95 · Cited by 4
Julian Davies and the discovery of kanamycin resistance transposon Tn5
Berg, D. E. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.120 · Cited by 6
Self-citationLong, G. S., Neale, M., Braukmann, T., Tran, V., Singh, N., Allen, V., Morshed, M. G., Minion, J., Caeseele, P. G. V., Vallée, M., et al. (2026) · Emerging infectious diseases · doi:10.3201/eid3202.251060 · Cited by 3
Gaillard, T., Wurtz, N., Houzé, S., Sriprawat, K., Wangsing, C., Hubert, V., Bras, J. L., Nosten, F. H., Briolant, S., & Pradines, B. (2015) · Malaria Journal · doi:10.1186/s12936-015-0878-x · Cited by 3
Antimicrobial Resistance and Drug Efflux Pumps in Helicobacter
Li, J. S. Y., & Li, X.-Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_19 · Cited by 3
Torres, L. E., Rodríguez, E. E., Hernández, M., Moreno, A., Roblejo, Y., Samada, M., Cansino, J. G., Ysla, K. M., Alonso, J., Martínez, M., et al. (2008) · Revista CENIC. Ciencias biológicas · Cited by 3
Patents on tetracycline and tetracycline derivatives as antimicrobials: January 1998 ? October 2002
Podlogar, B. L., Ohemeng, K. A., & Barrett, J. F. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.4.467 · Cited by 3
Invasive and Non-Invasive Methods of Diagnosing H. pylori Infection: A Review of Current Practice
Fontenot, T., & Barber, A. E. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004779 · Cited by 2
Williams, K. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3tq5rk43 · Cited by 2
Zhou, X., Zhang, G., Liao, J. Q.-J., & Xia, H. H. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005256 · Cited by 1
Virulence factor and microbial drug resistance
Chaturvedi, S., Rajak, S., & Sharma, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31554-1.00016-9 · Cited by 1
Gao, F., Xiang, W., Zhang, X., Huang, X.-X., She, F., & Wen, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1552537 · Cited by 1
Escherichia coli and Antibiotic Resistance to Tetracycline Antibiotics
Dodgen, T. L. (2008) · Digital Commons (Liberty University) · Cited by 1
Falsafi, T., Anoushiravani, M., & Niknam, V. (2010) · African Journal of Microbiology Research · doi:10.5897/ajmr.9000703 · Cited by 1
Antimicrobial Resistance in Helicobacter and Campylobacter
McDermott, P. F., Simala‐Grant, J. L., & Taylor, D. E. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-595-8_13 · Cited by 1
King, Z. (2021) · Tuwhera (Auckland University of Technology) · Cited by 1
Antimicrobial Resistance in Helicobacter and Campylobacter
McDermott, P. F., & Mégraud, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_14
Zamora, O. R., Power, M. H., Torres-Domínguez, L. E., Bermúdez-Díaz, L., & Rodríguez, B. L. (2011) · Revista CENIC. Ciencias biológicas
Cogo, L. L. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Synopsis of Antimicrobial Resistance
Mégraud, F. (2016) · Springer eBooks · doi:10.1007/978-981-287-706-2_35
McDermott, P. F., & Taylor, D. E. (2014) · ASM Press eBooks · doi:10.1128/9781555817572.ch24
Molecular Identification of Staphylococcus spp Isolated from Clinical samples
Mohammad, T. K. (2018) · Journal of Biotechnology Research Center · doi:10.24126/jobrc.2018.12.1.544
Synopsis of Antimicrobial Resistance
Mégraud, F. (2023) · Springer eBooks · doi:10.1007/978-981-97-0013-4_38
Resistance reversal: Taiwan’s Helicobacter pylori trends defy global norms
Issa, T., Zalloua, P., & Issa, I. A. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i47.114789
Metadata
- Authors
- Dailidiene, D., Bertoli, M. T., Miciuleviciene, J., Mukhopadhyay, A. K., Dailide, G., Pascasio, M. A., Kupcinskas, L., & Berg, D. E.
- Affiliations
- Washington University in St. Louis (US)
- Departments of Molecular Microbiology and Genetics, Washington University Medical School, St. Louis, Missouri 63110
- Ministerio de Salud (SV)
- Department of Gastroenterology, Kaunas University of Medicine, Kaunas, 3000, Lithuania
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-12
- Volume
- 46
- Issue
- 12
- Pages
- 3940-3946
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC132778
- OpenAlex
- W2153045047
- Cited by
- 101
- References
- 50
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 8 · 2015: 5 · 2014: 7 · 2013: 1 · 2012: 4
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lithuanian University of Health Sciences (submittedVersion)
- Funders
- National Institutes of Health (2r01ai038166-04, 1r03ai049161-01, 5r01dk053727-04)
- U.S. Public Health Service
- National Institute of Allergy and Infectious Diseases (AI49161, AI 38166)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-52574, DK53727, P30DK052574)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Helicobacter pylori, tetracycline resistance, 16S rRNA mutations, multiple mutations, antibiotic resistance mechanisms, efflux pumps, porin, clinical isolates, genetic diversity
- MeSH terms
- Cells, Cultured, Mutation, RNA, Ribosomal, 16S, Tetracycline Resistance, Polymerase Chain Reaction, Helicobacter pylori
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review